| Literature DB >> 31195591 |
James R Tucker1,2, Ana Badea3, Richard Blagden4, Kerri Pleskach5, Sheryl A Tittlemier6, W G Dilantha Fernando7.
Abstract
Barley (Hordeum vulgare L.) is a multipurpose crop that can be harvested as grain or cut prior to maturity for use as forage. Fusarium head blight (FHB) is a devastating disease of barley that reduces quality of grain. FHB can also result in the accumulation of mycotoxins such as deoxynivalenol (DON). Breeding FHB resistant varieties has been a long-term goal of many barley-producing countries, including Canada. While the genetic basis of DON detoxification via production of less-phytotoxic conjugates such as DON-3-glucoside (DON3G) is well documented in barley, little information exists in reference to varietal response. Over two years, 16 spring, two-row barley genotypes, of importance to western Canadian barley breeding programs, were grown as short-rows and inoculated following spike emergence with a Fusarium graminearum conidia suspension. Half of the plots were harvested at soft dough stage and then dissected into rachis and grain components, whereas the remainder was harvested at maturity. Multiple Fusarium-mycotoxins were assayed using liquid chromatography-mass spectrometry. Mycotoxin content was elevated at the earlier harvest point, especially in the rachis tissue. DON3G constituted a significant percentage (26%) of total trichothecene content and thus its co-occurrence with DON should be considered by barley industries. DON3G was highly correlated with DON and 3-acetyl-deoxynivalenol (3ADON). The ratio of D3G/DON exhibited consistency across genotypes, however more-resistant genotypes were characterized by a higher ratio at the soft-dough stage followed by a decrease at maturity. Plant breeding practices that use DON content as a biomarker for resistance would likely result in the development of barley cultivars with lower total DON-like compounds.Entities:
Keywords: DON; FHB; Fusarium graminearum; Fusarium head blight; Hordeum vulgare; barley; deoxynivalenol; deoxynivalenol-3-glucoside; trichothecene
Mesh:
Substances:
Year: 2019 PMID: 31195591 PMCID: PMC6628427 DOI: 10.3390/toxins11060319
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Pedigree and origin of 16 two-row, hulled spring barley genotypes evaluated for reaction to Fusarium head blight in 2016 and 2017 at Brandon, Manitoba.
| Name (Alias 1) | Pedigree | Origin 2 | Type 3 | Release 4 |
|---|---|---|---|---|
| AAC Synergy (TR09208) | TR 02267/Newdale | CDN | MALT | 2012 |
| AC Metcalfe (TR232) | AC Oxbow/Manley | CDN | MALT | 1997 |
| CDC Austenson (TR06389) | TR358/94Ab12271 | CDN | GP/F | 2010 |
| CDC Bold (SD422) | SB88403/Tyra | CDN | GP | 1999 |
| CDC Copeland (TR150) | WM861-5/TR118 | CDN | MALT | 1999 |
| CDC Kendall (TR133) | Manley/SM85221 | CDN | MALT | 1999 |
| CDC Mindon (TR04378) | TR339/TR251 | CDN | GP | 2008 |
| Conlon (TR982) | Bowman*2/Birgitta dwarf//ND10232 | USA | MALT 5 | 2004 |
| Harbin | CHN | - | - | |
| HDE84194-622-1 | CHN | - | - | |
| Kutahya | NLD | - | - | |
| Norman (TR05915) | In vitro selection from CDC Kendall | CDN | MALT | 2009 |
| Shenmai 3 | Gobernadora /Humai 10 | CHN | - | - |
| TR04282 | Harbin/TR253//TR253 | CDN | MALT | - |
| TR05287 | Svanhals/AC Metcalfe//TR253 | CDN | MALT | - |
| Xena (TR975) | Stark/Baroness | USA | GP | 2002 |
1 Coding under evaluation in Western Canadian Cooperative Barley Registration Test. 2 CDN = Canada; CHN = China; NLD = Netherlands; USA = United States of America. 3 MALT = Malting; GP = General Purpose; GP/F = General Purpose, Forage. 4 Year of rights granted by Canadian Food Inspection Agency. Conlon was registered in USA in 1996. 5 Accepted for malting quality in USA but not in the Canadian market.
Figure 1Fusarium head blight symptoms of 16 inoculated barley genotypes over 2016–2017 at Brandon, MB. (A) Percent incidence (B) Percent severity. Error bars represent standard error. Red dashed line represents overall mean.
Analysis of variance (ANOVA) for deoxynivalenol (DON), deoxynivalenol-3-glucoside (DON3G), 3-acetyl-deoxynivalenol (3ADON) concentration and the ratio (DON3G/DON) for different sample types.
| Source | DON | DON3G | 3ADON | DON3G/DON | ||||
|---|---|---|---|---|---|---|---|---|
| F | Pr > F | F | Pr > F | F | Pr > F | F | Pr > F | |
|
| ||||||||
| Genotype | 4.09 | <0.0001 | 4.72 | <0.0001 | 5.27 | <0.0001 | 2.21 | 0.02 |
| Year | 2.96 | 0.16 | 5.58 | 0.08 | 16.92 | 0.01 | 6.74 | 0.01 |
| Genotype x Year | 2.17 | 0.02 | 2.51 | 0.01 | 9.15 | <0.0001 | 1.11 | 0.37 |
|
| ||||||||
| Genotype | 3.63 | 0.0002 | 2.43 | 0.01 | 2.12 | 0.03 | 4.72 | <0.0001 |
| Year | 5.81 | 0.07 | 1.38 | 0.3 | 3.43 | 0.07 | 12.01 | <0.001 |
| Genotype x Year | 1.5 | 0.13 | 2.1 | 0.02 | 5.24 | < 0.0001 | 3.51 | <0.001 |
|
| ||||||||
| Genotype | 4.31 | <0.0001 | 5.56 | <0.0001 | 3.14 | 0.001 | 9.51 | <0.0001 |
| Year | 5.36 | 0.08 | 10.07 | 0.03 | 16.39 | 0.02 | 23.04 | <0.0001 |
| Genotype x Year | 3.91 | <0.0001 | 2.53 | 0.01 | 4.32 | <0.0001 | 3.09 | <0.001 |
Least-squares means of 16 barley genotypes for deoxynivalenol (DON), deoxynivalenol-3-glucoside (DON3G), 3-acetyl-deoxynivalenol (3ADON) concentration (mg kg−1) and the percent molar ratio (DON3G/DON) for different sample types over years 2016–2017.
| Genotype | DON | DON3G | 3ADON | DON3G/DON | ||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| AAC Synergy | 19.5 | abc | 11.2 | a | 1.5 | a | 37% | a |
| AC Metcalfe | 12.9 | abc | 4.9 | ab | 1.4 | a | 25% | ab |
| CDC Austenson | 4.2 | bc | 2.1 | ab | 0.4 | a | 31% | ab |
| CDC Bold | 33.2 | ab | 14.0 | a | 2.8 | a | 27% | ab |
| CDC Copeland | 9.0 | abc | 3.3 | ab | 0.6 | a | 27% | ab |
| CDC Kendall | 11.0 | abc | 4.4 | ab | 1.0 | a | 26% | ab |
| CDC Mindon | 4.0 | c | 2.7 | b | 0.5 | a | 35% | ab |
| Conlon | 17.3 | abc | 6.0 | ab | 0.9 | a | 23% | ab |
| Harbin | 9.2 | c | 2.5 | b | 0.8 | a | 28% | ab |
| HDE84194-622-1 | 32.8 | a | 10.9 | a | 1.8 | a | 22% | ab |
| Kutahya | 5.8 | abc | 1.8 | b | 0.5 | a | 20% | b |
| Norman | 3.8 | c | 1.8 | b | 0.3 | a | 28% | ab |
| Shenmai 3 | 17.8 | abc | 5.7 | ab | 1.4 | a | 25% | ab |
| TR 04282 | 14.4 | abc | 6.0 | ab | 1.5 | a | 24% | ab |
| TR 05287 | 14.7 | abc | 6.4 | ab | 1.3 | a | 29% | ab |
| Xena | 11.4 | abc | 4.4 | ab | 1.0 | a | 27% | ab |
| Overall Mean | 13.8 | 5.5 | 1.1 | 27% | ||||
|
| ||||||||
| AAC Synergy | 34.0 | ab | 40.1 | a | 2.3 | a | 89% | abc |
| AC Metcalfe | 17.7 | abc | 15.2 | ab | 1.8 | a | 73% | abc |
| CDC Austenson | 6.1 | bc | 7.4 | ab | 0.8 | a | 95% | ab |
| CDC Bold | 28.7 | abc | 37.7 | a | 2.5 | a | 88% | abc |
| CDC Copeland | 13.0 | abc | 13.7 | ab | 0.8 | a | 69% | abc |
| CDC Kendall | 15.8 | abc | 16.3 | ab | 1.3 | a | 99% | abc |
| CDC Mindon | 8.6 | abc | 8.0 | ab | 1.0 | a | 75% | abc |
| Conlon | 26.5 | abc | 10.1 | ab | 1.1 | a | 48% | cd |
| Harbin | 12.8 | c | 11.8 | ab | 1.1 | a | 111% | a |
| HDE84194-622-1 | 48.8 | a | 22.9 | ab | 3.7 | a | 29% | d |
| Kutahya | 5.6 | bc | 5.9 | b | 0.3 | a | 57% | bcd |
| Norman | 5.1 | c | 5.6 | ab | 0.3 | a | 85% | abc |
| Shenmai 3 | 17.2 | abc | 9.2 | ab | 1.0 | a | 35% | cd |
| TR 04282 | 18.1 | abc | 16.5 | ab | 1.9 | a | 60% | abcd |
| TR 05287 | 20.3 | abc | 17.8 | ab | 1.7 | a | 65% | abc |
| Xena | 16.6 | abc | 15.8 | ab | 1.5 | a | 61% | abc |
| Overall Mean | 18.4 | 15.9 | 1.5 | 71% | ||||
|
| ||||||||
| AAC Synergy | 10.3 | abc | 4.9 | abcd | 0.6 | ab | 31% | a |
| AC Metcalfe | 12.9 | abc | 4.4 | abcd | 0.7 | ab | 22% | bcd |
| CDC Austenson | 5.7 | bc | 1.6 | cde | 0.3 | b | 17% | f |
| CDC Bold | 19.2 | ab | 6.9 | abc | 1.2 | a | 22% | bcd |
| CDC Copeland | 11.8 | abc | 4.5 | abcde | 0.8 | ab | 29% | ab |
| CDC Kendall | 10.1 | abc | 4.1 | abcde | 0.6 | ab | 26% | abc |
| CDC Mindon | 4.9 | c | 1.4 | e | 0.3 | ab | 19% | df |
| Conlon | 15.5 | ab | 5.8 | ab | 0.6 | ab | 23% | abcd |
| Harbin | 6.5 | bc | 1.5 | d | 0.3 | ab | 15% | f |
| HDE84194-622-1 | 26.0 | a | 8.2 | a | 1.1 | a | 26% | abcd |
| Kutahya | 7.2 | abc | 2.4 | abcde | 0.3 | ab | 22% | bcd |
| Norman | 4.1 | c | 1.6 | bcde | 0.2 | b | 24% | abcd |
| Shenmai 3 | 18.6 | ab | 7.1 | a | 0.7 | ab | 26% | abc |
| TR 04282 | 7.8 | abc | 3.2 | abcde | 0.6 | ab | 25% | abcd |
| TR 05287 | 9.9 | abc | 3.9 | abcde | 0.5 | ab | 25% | abcd |
| Xena | 9.7 | abc | 3.2 | abcde | 0.5 | ab | 21% | cd |
| Overall Mean | 11.3 | 4.0 | 0.6 | 23% | ||||
Note: Letter following represents significance group from Tukey-Kramer Honest Significant Difference test), where shared letters indicate values that do not differ significantly. Means have been back-transformed to original scale.
Figure 2Pearson correlation coefficients for visual symptoms and mycotoxin content (mg kg−1), where Head = Days to 75% of spikes headed; Incidence = Percentage of infected spikes per plot; Severity = Percentage of infected grains per infected spike; DON = deoxynivalenol; DON3G = deoxynivalenol-3-glucoside; 3ADON = 3-acetyl-deoxynivalenol; Ratio = DON3G/DON. (A) grain tissue harvested at soft-dough stage. (B) rachis tissue harvested at soft-dough stage. (C) grain tissue harvested at maturity.
Figure 3Linear relationship of deoxynivalenol-3-glucoside (DON3G) with deoxynivalenol (DON) content in matured grains. Shaded area represents 95% confidence interval for the fitted line.
Figure 4Left axis: Deoxynivalenol (DON) concentration (light blue line) and total DON + deoxynivalenol-3-glucoside (DON3G) concentration (black line) in grain; Corresponding logarithmic fit lines (broken lines). Right Axis: Ratio of DON3G to DON at soft-dough (green line) or mature stage (red line) for 16 barley genotypes organized in ascending order for mean DON content at maturity over 2016–2017.